PL432480A1 - Eplerenone preparation in the form of orodispersible tablets - Google Patents

Eplerenone preparation in the form of orodispersible tablets

Info

Publication number
PL432480A1
PL432480A1 PL432480A PL43248019A PL432480A1 PL 432480 A1 PL432480 A1 PL 432480A1 PL 432480 A PL432480 A PL 432480A PL 43248019 A PL43248019 A PL 43248019A PL 432480 A1 PL432480 A1 PL 432480A1
Authority
PL
Poland
Prior art keywords
eplerenone
preparation
subject
application
orodispersible tablets
Prior art date
Application number
PL432480A
Other languages
Polish (pl)
Inventor
Michał Tynderynda
Anna Kopcińska
Marta Majewska
Original Assignee
Sieć Badawcza Łukasiewicz - Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sieć Badawcza Łukasiewicz - Instytut Farmaceutyczny filed Critical Sieć Badawcza Łukasiewicz - Instytut Farmaceutyczny
Priority to PL432480A priority Critical patent/PL432480A1/en
Publication of PL432480A1 publication Critical patent/PL432480A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Przedmiotem zgłoszenia jest preparat farmaceutyczny w postaci tabletek ulegających rozpadowi w jamie ustnej zawierających substancję czynną eplerenon lub jego farmaceutycznie dopuszczalną sól lub solwat wytwarzany metodą bezpośredniego tabletkowania, zapewniający czas rozpadu w jamie ustnej poniżej 40 sekund. Przedmiotem zgłoszenia jest też sposób wytwarzania preparatu farmaceutycznego w postaci tabletek ulegających rozpadowi w jamie ustnej zawierających eplerenon, obejmujący następujące etapy: a) połączenie substancji czynnej, wypełniającej, rozsadzającej i smarującej/poślizgowej poprzez ich mieszanie do uzyskania homogenicznej mieszanki, b) ewentualnie, wprowadzenie do mieszanki pozostałych substancji pomocniczych, c) poddanie mieszanki kompresji do uzyskania tabletek.The subject of the application is a pharmaceutical preparation in the form of orodispersible tablets containing the active ingredient eplerenone or a pharmaceutically acceptable salt or solvate thereof produced by direct tabletting, with a disintegration time in the oral cavity of less than 40 seconds. The subject of the application is also a method for the preparation of a pharmaceutical preparation in the form of orally disintegrating tablets containing eplerenone, comprising the following steps: a) combining the active, filler, disintegrant and lubricant / glidant substance by mixing them to a homogeneous mixture, b) optionally, introducing them into blends of the remaining excipients, c) compressing the blend into tablets.

PL432480A 2019-12-31 2019-12-31 Eplerenone preparation in the form of orodispersible tablets PL432480A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL432480A PL432480A1 (en) 2019-12-31 2019-12-31 Eplerenone preparation in the form of orodispersible tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL432480A PL432480A1 (en) 2019-12-31 2019-12-31 Eplerenone preparation in the form of orodispersible tablets

Publications (1)

Publication Number Publication Date
PL432480A1 true PL432480A1 (en) 2021-07-05

Family

ID=76689624

Family Applications (1)

Application Number Title Priority Date Filing Date
PL432480A PL432480A1 (en) 2019-12-31 2019-12-31 Eplerenone preparation in the form of orodispersible tablets

Country Status (1)

Country Link
PL (1) PL432480A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2638418A (en) * 2024-02-21 2025-08-27 Novumgen Ltd An orodispersible tablet of spironolactone and its process of preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2638418A (en) * 2024-02-21 2025-08-27 Novumgen Ltd An orodispersible tablet of spironolactone and its process of preparation

Similar Documents

Publication Publication Date Title
US20250000862A1 (en) Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
US10307400B2 (en) Orally disintegrating tablet containing asenapine
US20190054088A1 (en) Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis
NO20052019L (en) Mixture to inhibit gastric acid secretion
HUP0105173A2 (en) Dosage regimen and pharmaceutical composition for emergency contraception
Landwehr et al. A comparison between IV paracetamol and IV metamizol for postoperative analgesia after retinal surgery
CA2620594A1 (en) Pharmaceutical composition having improved disintegratability
NZ573174A (en) Sustained release pharmaceutical dosage form containing phenylephrine
RU2016117186A (en) COMBINED COMPOSITION CONTAINING TADALAFIL AND AMLODIPINE
EP1392271B1 (en) Swallow tablet comprising paracetamol
RU2008119410A (en) DISPERSABLE TABLETS INCLUDING DEFERASYROX
CN105407925A (en) Manufacturing process for effervescent dosage forms
PL432480A1 (en) Eplerenone preparation in the form of orodispersible tablets
JP7116277B2 (en) Granules, tablets and manufacturing method thereof
US20060222703A1 (en) Pharmaceutical composition and preparation method thereof
AU2023309035A1 (en) Methods of administering nalbuphine
HRP20251043T1 (en) A NEW ORAL PHARMACEUTICAL PREPARATION AND DOSAGE REGIME FOR THE THERAPY OF PROGRESSIVE FIBROSITISING INTERSTITIAL LUNG DISEASES
JP6863401B2 (en) Solid preparation
ES2443968T3 (en) Olmesartan pharmaceutical compositions
PL432676A1 (en) Preparation of bosentan in the form of orodispersible tablets
AU2003214326B2 (en) Orally dispersible pharmaceutical piribedil composition
JP2006298912A (en) Medical composition
MX2026001621A (en) Oral pharmaceutical dosage form providing immediate release of vidofludimus
TW202400131A (en) Guanfacine hydrochloride containing pharmaceutical preparation
TW201311266A (en) Excipient compatibility with ezatiostat